Drug Discovery Informatics Market Size, Share, Trends, Growth and Forecast 2032

Drug Discovery Informatics Market

Drug Discovery Informatics Market Size, Share (Outsourced Informatics; In-House Informatics & Off-Premise Outsourced Informatics And Services) For Docking, Enterprises (Small, Mid And Large-Size Enterprises) And Law Firms - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends And Forecast, 2024-2032

Category: Pharmaceutical Report Format : PDF Pages: 140 Report Code: ZMR-40 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 3.38 Billion USD 11.19 Billion 14.22% 2023

Drug Discovery Informatics Market

Request For Customization Request Free Sample Buy Now

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Mode
        • 2.1.1.2. Market Attractiveness Analysis, By Service
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Drug Discovery Informatics, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Drug Discovery Informatics – Component Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Mode, 2020 & 2028
    • 4.2. Outsourced Informatics
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. In-House Informatics
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Drug Discovery Informatics – Service Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Service, 2020 & 2028
    • 5.2. Docking
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Modular Modeling
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Drug Discovery Informatics – Region Segment Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Mode, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Service, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Mode, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Service, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Mode, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Service, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Mode, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Service, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Mode, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Service, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Mode, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Service, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Mode, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Service, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Mode, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Service, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Mode, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Service, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Mode, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Service, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Mode, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Service, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Mode, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Service, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Mode, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Service, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Mode, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Service, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Mode, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Service, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Mode, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Service, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Mode, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Service, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Mode, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Service, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Mode, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Service, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Mode, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Service, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Mode, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Service, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Mode, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Service, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Mode, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Service, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Mode, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Service, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Mode, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Service, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Mode, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Service, 2016 – 2028
  • Chapter No. 7: Drug Discovery Informatics – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Drug Discovery Informatics: Company Market Share, 2019
      • 8.1.2. Global Drug Discovery Informatics, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Drug Discovery Informatics, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Drug Discovery Informatics: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Certara
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
    • 9.2 Certara
    • 9.3 Boehringer Ingelheim International GmbH
    • 9.4 Infosys Ltd.
    • 9.5 Charles River Laboratories
    • 9.6 Cullaborative Drug Discovery, Inc.
    • 9.7 Eurofins DiscoverX Products
    • 9.8 Jubilant Biosys
    • 9.9 Selvita
    • 9.10 Novo Informatics Pvt. Ltd.
    • 9.11 ChemAxon Ltd.
    • 9.12 Albany Mulecular Research Inc.
    • 9.13 Oracle
    • 9.14 Accenture
    • 9.15 Agilent Technulogies, Inc.
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Mode
FIG NO. 2. Market Attractiveness Analysis, By Service
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Drug Discovery Informatics Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Mode, 2020 & 2028 
FIG NO. 7. Global Drug Discovery Informatics for Outsourced Informatics, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Drug Discovery Informatics for Outsourced Informatics, By Country, 2020 & 2028
FIG NO. 9. Global Drug Discovery Informatics for In-House Informatics, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Drug Discovery Informatics for In-House Informatics, By Country, 2020 & 2028
FIG NO. 11. Market Revenue Share, By Service, 2020 & 2028
FIG NO. 12. Global Drug Discovery Informatics for Docking, Revenue (USD Billion) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Drug Discovery Informatics for Docking, By Country, 2020 & 2028 
FIG NO. 14. Global Drug Discovery Informatics for Modular Modeling, Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Drug Discovery Informatics for Modular Modeling, By Country, 2020 & 2028
FIG NO. 16. Global Drug Discovery Informatics Revenue Share, By Region, 2020 & 2028
FIG NO. 17. North America Drug Discovery Informatics Revenue, 2016 - 2028 (USD Billion)
FIG NO. 18. Porter’s Five Forces Analysis for Global Drug Discovery Informatics
FIG NO. 19. PEST Analysis for Global Drug Discovery Informatics
FIG NO. 20. Pricing Analysis for Global Drug Discovery Informatics
FIG NO. 21. Value Chain Analysis for Global Drug Discovery Informatics
FIG NO. 22. Company Share Analysis, 2019
FIG NO. 23. Radar Determinant Chart, 2019
FIG NO. 24. Company Strategic Developments – Heat Map Analysis
FIG NO. 25. Royal DSM Company Business Segment Revenue Share, 2020 (%)
FIG NO. 26. Royal DSM  Company Geographical Segment Revenue Share, 2020 (%)
FIG NO. 27. Market Channels
FIG NO. 28. Marketing Channel Development Trend
FIG NO. 29. Growth in World Gross Product, 2008-2018
FIG NO. 30. Research Methodology – Detailed View
FIG NO. 31. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Drug Discovery Informatics: Snapshot
TABLE NO. 2. Quarterly Drug Discovery Informatics Revenue by Region, 2020
TABLE NO. 3. Quarterly Drug Discovery Informatics Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Drug Discovery Informatics for Outsourced Informatics, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Drug Discovery Informatics for In-House Informatics, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Drug Discovery Informatics for Docking, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9 Global Drug Discovery Informatics for Modular Modeling, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10 Global Drug Discovery Informatics Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. North America Drug Discovery Informatics Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 12. North America Drug Discovery Informatics Revenue, By Mode, 2016 – 2028 (USD Billion)
TABLE NO. 13. North America Drug Discovery Informatics Revenue, By Service, 2016 – 2028 (USD Billion)
TABLE NO. 14. U.S. Drug Discovery Informatics Revenue, By Mode, 2016 – 2028 (USD Billion)
TABLE NO. 15. U.S. Drug Discovery Informatics Revenue, By Service, 2016 – 2028 (USD Billion)
TABLE NO. 16. Canada Drug Discovery Informatics Revenue, By Mode, 2016 – 2028 (USD Billion)
TABLE NO. 17. Canada Drug Discovery Informatics Revenue, By Service, 2016 – 2028 (USD Billion)
TABLE NO. 18. Mexico Drug Discovery Informatics Revenue, By Mode, 2016 – 2028 (USD Billion)
TABLE NO. 19. Mexico Drug Discovery Informatics Revenue, By Service, 2016 – 2028 (USD Billion)
TABLE NO. 20. Drivers for the Drug Discovery Informatics: Impact Analysis
TABLE NO. 21. Restraints for the Drug Discovery Informatics: Impact Analysis
TABLE NO. 22. Major Buyers of Aquaculture
TABLE NO. 23. Distributors/Traders List of Aquaculture
TABLE NO. 24. Global Drug Discovery Informatics, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 25: Global Drug Discovery Informatics, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   


 

Methodology

FrequentlyAsked Questions

Drug Discovery Informatics Market size worth at USD 3.38 Billion in 2023

Drug Discovery Informatics Market size worth at USD 3.38 Billion in 2023 and projected to USD 11.19 Billion by 2032, with a CAGR of around 14.22% between 2024-2032.

Escalating demand for quick data access and the rising need for minimizing costs of drug discovery as a result of easy availability of information will spur the drug discovery informatics market.

North America is the largest market for drug discovery informatics in the world. Out of all the 50 states in the country, 49 states have already enacted e-discovery rules.  The large share of North America in the global market can be attributed to the presence of well-established CROs, increasing R&D expenditure by pharmaceutical and biopharmaceutical companies.

Key manufacturers included in the study are ertara, Boehringer Ingelheim International GmbH, Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita, Novo Informatics Pvt. Ltd., ChemAxon Ltd., Albany Molecular Research Inc., Oracle, Accenture, Agilent Technologies, Inc., Illumina, Inc. and amongst others.

Choose License Type

  • zion payment modes

List of Contents

Market InsightsMarket Size Overview COVID-19 Impact Analysis Global Market Size: Growth Factors Report ScopeMode Segment Analysis Preview Service Segment Analysis Preview Regional Segment Analysis Preview Key Market Players Competitive LandscapeThe global is segmented as follows:By Region

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed